Your browser doesn't support javascript.
loading
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA Vaccines.
Rohde, Cynthia M; Lindemann, Claudia; Giovanelli, Michael; Sellers, Rani S; Diekmann, Jan; Choudhary, Shambhunath; Ramaiah, Lila; Vogel, Annette B; Chervona, Yana; Muik, Alexander; Sahin, Ugur.
Affiliation
  • Rohde CM; Drug Safety Research and Development, Pfizer Worldwide Research, Development & Medical, Pfizer, Inc., Pearl River, NY 10965, USA.
  • Lindemann C; BioNTech SE, 55131 Mainz, Germany.
  • Giovanelli M; Drug Safety Research and Development, Pfizer Worldwide Research, Development & Medical, Pfizer, Inc., Groton, CT 06340, USA.
  • Sellers RS; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Diekmann J; BioNTech SE, 55131 Mainz, Germany.
  • Choudhary S; Drug Safety Research and Development, Pfizer Worldwide Research, Development & Medical, Pfizer, Inc., Pearl River, NY 10965, USA.
  • Ramaiah L; Drug Safety Research and Development, Pfizer Worldwide Research, Development & Medical, Pfizer, Inc., Pearl River, NY 10965, USA.
  • Vogel AB; BioNTech SE, 55131 Mainz, Germany.
  • Chervona Y; Drug Safety Research and Development, Pfizer Worldwide Research, Development & Medical, Pfizer, Inc., Pearl River, NY 10965, USA.
  • Muik A; BioNTech SE, 55131 Mainz, Germany.
  • Sahin U; BioNTech SE, 55131 Mainz, Germany.
Vaccines (Basel) ; 11(2)2023 Feb 11.
Article in En | MEDLINE | ID: mdl-36851293

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2023 Document type: Article Affiliation country: United States